John Overdeck’s PRA Health Sciences, Inc. PRAH Stock Holding History

John Overdeck’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,200	Closed	-$515K	–	3731
2020 Q1	$515K	Buy	6,200 +2,900	+88%	+$283K	﹤0.01%	1907
2019 Q4	$367K	Sell	3,300 -2,500	-43%	-$257K	﹤0.01%	3037
2019 Q3	$576K	Sell	5,800 -1,000	-15%	-$99.3K	﹤0.01%	2442
2019 Q2	$674K	Buy	+6,800	New	+$649K	﹤0.01%	2270

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

John Overdeck's PRAH Position: Q3 2021 in Review

John Overdeck sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 525,778 shares — an estimated $86.9M sold.

John Overdeck first reported a position in PRAH in Q2 2015 and held it in 9 quarters. The position peaked at $86.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

John Overdeck reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
John Overdeck sold 525,778 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $86.9M.
John Overdeck first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 9 quarters.
John Overdeck's PRA Health Sciences, Inc. position peaked at $86.9M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.